University of Edinburgh
Molecular mechanisms of Bacillus subtilis protection against α-synuclein aggregation in a C. elegans model
Abstract
dc:description.abstractParkinson’s disease is the second most common degenerative disease worldwide, affecting over 1% of the population over 60 years. Pathologically, the disease is defined by the accumulation of α-synuclein in the form of Lewy bodies and the degeneration of dopaminergic neurons, which causes the motor symptoms that characterize the disease. In recent years, research has shed light on the existence of a relationship between the gut microbiota and the brain, and on the fact that this microbiota can influence the onset and progression of Parkinson’s. However, the mechanisms by which this happens haven’t been fully elucidated yet. Previous work using a C. elegans model of synucleinopathy showed that a probiotic B. subtilis inhibits and reverses α-synuclein aggregation when fed to the animals. Evidence suggests that B. subtilis mediates this protective effect by altering the physiology of the host. The central hypothesis of this work is that gene expression changes in C. elegans induced by the B. subtilis diet causally contribute to the reduction of α-synuclein aggregation. The aim of this work was to explore the genetic and molecular mechanisms that underlie this protective effect. This was done by analysing comparative transcriptomics data from C. elegans exposed to different bacterial diets. This analysis resulted in a list of potentially protective genes that are upregulated in the host upon exposure to different diets that contain B. subtilis. These upregulated genes belonged to immune defence response and different metabolic pathways, including lipid and sphingolipid metabolism. The genes from this list were then tested in a reverse genetic screen, where C. elegans strains carrying a loss-of-function mutation for each of the genes were crossed to the synucleinopathy model. The resulting strains were tested to check whether inactivation of the gene would change α-synuclein aggregation in the animals when fed their regular E. coli OP50 diet or the protective B. subtilis. Out of the 28 genes screened, eight showed an effect on α-synuclein aggregation, including the gba genes, which encode the worm’s glucocerebrosidase, a lysosomal enzyme that converts glucocerebroside into ceramide. GBA in humans is one of the most common genetic risk factors for Parkinson’s disease when it is mutated, and C. elegans has four different orthologs of this gene with the same predicted function. Knocking out all four gba paralogs in C. elegans had an impact on α-synuclein aggregation in animals fed on the B. subtilis diet, but not on the regular laboratory E. coli diet. Furthermore, in the gba knockout strain B. subtilis diet did not reverse α-synuclein aggregation, suggesting a role of this gene in the B. subtilis protective effect. Reintroduction of gba-3 in the gba knockout strain could rescue the phenotype, further confirming the role of gba. The gba knockout worms were used to assess the functional role of human GBA mutations that are known risk factors for Parkinson’s. Lastly, it was investigated whether overexpression of gba in the C. elegans synucleinopathy model could reduce aggregation in a diet-independent manner. These experiments further confirmed the role of gba in the protective effect. Taken together, these results establish C. elegans as a model to study molecular mechanisms of GBA function. Moreover, they provide evidence of microbiota–host genotype interactions in the context of Parkinson’s and the potential influence of the microbiota on the effects of GBA activity. Lastly, they increase our mechanistic understanding of the B. subtilis protective effect against α-synuclein aggregation, which could inform future translational research.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Paz Recio, Samanta
- Advisors dc:contributor.advisor
-
- Doitsidou, Maria
- Kunath, Tilo
- Jarman, Andrew
- Cheerambathur, Dhanya
Subjects
dc:subject × 6Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.7488/era/7748